Concepedia

Thomas Galbo

TG

7

Publications

448

Citations

7

H-Index

2011

Active since

Affiliations

Yale University(Current)

Novo Nordisk (Denmark)

University of Copenhagen

Howard Hughes Medical Institute

Karolinska Institutet

Thomas Galbo is an author at Yale University specializing in cell signaling, medicine, and cell biology.

Top concepts

Publications per year

2011–2015

7

Publications

7

Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo

Thomas Galbo, Rachel J. Perry, Michael J. Jurczak et al. · Proceedings of the National Academy of Sciences · 2013 · 99 citations · Full text

, , +19

Histone deacetylase 3 inhibition improves glycaemia and insulin secretion in obese diabetic rats

Morten Lundh, Thomas Galbo, Steen Seier Poulsen et al. · Diabetes Obesity and Metabolism · 2015 · 96 citations

An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in β-Cell Protection

Florence F. Wagner, Morten Lundh, Taner Kaya et al. · ACS Chemical Biology · 2015 · 83 citations · Full text

, , +20

Free Fatty Acid-Induced PP2A Hyperactivity Selectively Impairs Hepatic Insulin Action on Glucose Metabolism

Thomas Galbo, Grith Skytte Olsen, Bjørn Quistorff et al. · PLoS ONE · 2011 · 54 citations · Full text

Pancreatic islet and progenitor cell surface markers with cell sorting potential

Jacob Hald, Thomas Galbo, Claude Rescan et al. · Diabetologia · 2011 · 47 citations · Full text

, , +7

Rows per page

1–5 of 7